Lv4
646 积分 2024-09-18 加入
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4 , a novel once‐weekly basal insulin, in healthy participants: A randomized trial
2天前
待确认
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4 , a novel once‐weekly basal insulin, in healthy participants: A randomized trial
2天前
已关闭
Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study
2天前
已完结
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial
2天前
已完结
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial
2天前
已完结
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
2天前
已完结
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
2天前
已完结
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
2天前
已完结
Correspondence - Tranexamic acid for traumatic brain injury
2天前
已关闭
Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
9天前
已完结
皖公网安备34019202002308
